Realizing the Promise of Cell and Gene Therapy with an Advanced Manufacturing Platform

January 31, 2022PAO-01-22-R250-15

As part of the Road to 50 States campaign, Inceptor Bio's Founder and CEO Shailesh Maingi and CSO Mike Nicholson speak to Nigel about the promise of cell and gene therapy, Inceptor's strategy and the new GMP manufacturing facility that will house the company's advanced manufacturing platform (AMP).

chat button